Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

Title
Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-05
DOI
10.1111/all.14035

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started